The impact of obesogenic disturbances on in vitro fertilization outcomes in a Mexican population
Reproduction, Fertility and Development · 2025
DOI: 10.1071/rd25072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproduction, Fertility and Development, 2025. Verfasst von Yúvika Reyes-Albarracín und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional Cinvestav-IPN, Avenida Instituto Poli…. Hauptthemen laut MEDLINE: Fertilization in Vitro, Obesity, Infertility, Female. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Context
Overweight and obese patients tend to have more difficulty getting pregnant through in vitro fertilization (IVF), but it is still unclear whether this effect varies by ethnicity and age.
Aims
To assess the effect obesity has on IVF among infertile, advanced-age (≥ 35 years) Mexican women.
Methods
Retrospectively, data were collected from the INGENES Institute (2018–2022; n = 2,232). Pearson’s correlation coefficient (r) was calculated to evaluate associations. The area under the receiver operating characteristic curve (AUC) determined the predictability of body mass index (BMI) for IVF with the highest Youden index score (sensitivity + specificity – 1) as the optimal cutoff value. Logistic regression was used to calculate risk (odds ratios (ORs) with 95% confidence intervals (95%CIs)). Key results BMI was negatively correlated with IVF outcomes (P < 0.001): biochemical pregnancy (r = −0.164), clinical pregnancy (r = −0.188), and live birth (r = −0.202). BMI cutoffs to predict IVF success were: ≤ 25.1 kg/m2 for biochemical pregnancy (AUC = 0.63; specificity = 71.4%; sensitivity = 50.1%); ≤ 24.0 kg/m2 for clinical pregnancy (AUC = 0.65; specificity = 85.3%; sensitivity = 40.2%), and ≤ 24.0 kg/m2 for live birth (AUC = 0.67; specificity = 85.7%; sensitivity = 44.4%). Overweight or obese patients had higher risks of not having transferable embryos (OR = 2.7, 95%CI: 2.1–3.4 and OR = 3.8, 95%CI: 2.5–5.6, respectively, P < 0.001) and failed embryo implantation (OR = 3.1, 95%CI: 2.3–3.9 and OR = 4.7, 95%CI: 3.2–7.1, respectively, P < 0.001). The risk of pregnancy loss was also higher in patients who were overweight (OR = 4.7, 95%CI: 2.4–9.4, P < 0.001) and obese (OR = 4.0, 95%CI: 1.5–10.8, P = 0.006).
Conclusion
BMI was highly associated with and predicted IVF failure.
Implications
Obesity is a prevalent factor that affects each stage of IVF; diet and other weight management treatments need to be implemented to promote IVF success.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional Cinvestav-IPN, Avenida Instituto Politécnico Nacional 2508 Colonia San Pedro Zacatenco, Ciudad de México 07…
- Instituto de Infertilidad y Genética México S.C., Ingenes, Carretera México-Toluca 5420, Oficina 602, Colonia El Yaqui, Ciudad de México 05320, México.
- Departamento de Genética, Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Calle 13 Sur 2702, Colonia Los Volcanes, Puebla 72420, México.
ORCID-Profile: Esther López-Bayghen
Zitieren
APA
Reyes-Albarracín, Y., Porchia, L. M., Gonzalez-Mejia, M. E., & López-Bayghen, E. (2025). The impact of obesogenic disturbances on in vitro fertilization outcomes in a Mexican population. Reproduction, Fertility and Development. https://doi.org/10.1071/rd25072
Vancouver
Reyes-Albarracín Y, Porchia LM, Gonzalez-Mejia ME, López-Bayghen E. The impact of obesogenic disturbances on in vitro fertilization outcomes in a Mexican population. Reproduction, Fertility and Development. 2025. doi:10.1071/rd25072
BibTeX
@article{ReyesAlbarracn2025,
author = {Reyes-Albarracín, Yúvika and Porchia, Leonardo M and Gonzalez-Mejia, M Elba and López-Bayghen, Esther},
title = {The impact of obesogenic disturbances on in vitro fertilization outcomes in a Mexican population},
journal = {Reproduction, Fertility and Development},
year = {2025},
doi = {10.1071/rd25072}
}
EUVIMED